Chemoinformaics analysis of Santalyl acetate
| Molecular Weight | 262.393 | nRot | 5 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 25 |
| Exact Molecular Weight | 262.193 | nRing | 2 |
| Solubility: LogS | -4.354 | nHRing | 0 |
| Solubility: LogP | 2.935 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 47.3306 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.695 |
| Synth | 5.675 |
| Natural Product Likeliness | 3.012 |
| NR-PPAR-gamma | 0.208 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.001 |
| HIA | 0.045 |
| CACO-2 | -4.702 |
| MDCK | 0.0000371 |
| BBB | 0.982 |
| PPB | 0.866684 |
| VDSS | 0.793 |
| FU | 0.0885841 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.402 |
| CYP2c19-inh | 0.116 |
| CYP2c19-sub | 0.778 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.165 |
| CYP2d6-inh | 0.132 |
| CYP2d6-sub | 0.086 |
| CYP3a4-inh | 0.883 |
| CYP3a4-sub | 0.765 |
| CL | 15.611 |
| T12 | 0.168 |
| hERG | 0.045 |
| Ames | 0.007 |
| ROA | 0.607 |
| SkinSen | 0.033 |
| Carcinogencity | 0.905 |
| EI | 0.011 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.783635 |